DIWALI SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

ARVEE vs SUDARSHAN: Stock Comparison

ARVEE vs SUDARSHAN PHARMA INDUpdated 11 Nov 26, 4:08 PM ISTNSE & company filings

ARVEE shows faster revenue growth and a higher net margin, while SUDARSHAN PHARMA IND shows a lower P/E. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

ARVEE leads 6; SUDARSHAN leads 2 of 9

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

ARVEESUDARSHAN

Valuation lens

What price are you paying?

Market CapContext only
₹245 Cr
₹0 Cr
P/E RatioSUDARSHAN has the lower reading
69.87x
28.27x ✓
P/B RatioSUDARSHAN has the lower reading
5.22x
4.11x ✓
EPSARVEE has the higher reading
₹2.32 ✓
₹0.32
Book ValueContext only
₹30.66
₹6.14
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

P/E Ratio
SUDARSHAN has a lower P/E
28.27x vs 69.87x
P/B Ratio
SUDARSHAN has a lower P/B
4.11x vs 5.22x
EPS
ARVEE has higher earnings per share
₹2.32 vs ₹0.32
Revenue Growth (TTM YoY)
ARVEE has faster revenue growth
67.5% vs 0%
EPS Growth (TTM YoY)
ARVEE has faster EPS growth
684.4% vs 0%
Qtr Sales Growth
ARVEE has stronger quarterly sales growth
44.72% vs 24.4%
Qtr Profit Growth
ARVEE has stronger quarterly profit growth
50.87% vs 38.7%
Net Margin
ARVEE has a higher net margin
7.65% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricARVEESUDARSHAN
SectorChemicals—
IndustrySpecialty Chemicals—

Price

MetricARVEESUDARSHAN
Live Price₹228.06₹32.71
Day Change0.21%0.03%
Volume3,87092,985
52-Week High₹290.78₹39.3
52-Week Low₹129.11₹31.01
Distance from 52W High-21.57%-16.77%

Valuation

MetricARVEESUDARSHAN
Market Cap₹245 Cr₹0 Cr
P/E Ratio69.87x28.27x
P/B Ratio5.22x4.11x
EPS₹2.32₹0.32
Book Value₹30.66₹6.14
Dividend Yield0%0%

Growth

MetricARVEESUDARSHAN
Revenue Growth (TTM YoY)67.5%0%
EPS Growth (TTM YoY)684.4%0%
Qtr Sales Growth44.72%24.4%
Qtr Profit Growth50.87%38.7%

Profitability & Leverage

MetricARVEESUDARSHAN
ROE7.48%—
ROCE7.73%—
Net Margin7.65%0%
Operating Margin8.46%—
Debt to Equity0.03x—

Shareholding

As of Sep 2026 • change vs previous quarter
MetricARVEESUDARSHAN
Promoter Holding73.5%57.81%▼ 1.12 pp
FII Holding0%21.95%▲ 2.57 pp
DII Holding0%0%
Public Holding26.5%20.19%▼ 1.45 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ARVEE and SUDARSHAN PHARMA IND.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.